ETFS S&P Biotech ETF (ASX:CURE) Short Interest & Short Position History
The data below is sourced from ASIC, which is supplied on a T+4 basis (trading-day plus four days). The accuracy of the below data is unlikely to be perfect, as it is reliant on organisations, both domestic and foreign, reporting accruate short positions on any given day.
As per the latest ASIC data for CURE (29 June 2026), CURE is the 408th most shorted stock on the ASX by percentage of total shares issued.
As per the latest ASIC data for CURE (29 June 2026), CURE is the 408th most shorted stock on the ASX by percentage of total shares issued.
|
% Shorted 0.21% 0.21 |
Shorted Shares 1,377 |
Short Rank 408th (408/710) |
Peak Short 0.61% (Jun 2021) |
Days to Cover 0.7 (50d avg vol) |
Latest Reported Shorts (Aggregate)
| Date | Reported Short | Issued Shares | % Short | Daily Rank |
|---|---|---|---|---|
| 29 June 2026 | 1,377 | 644,012 | 0.2138% | 408th 295 |
| 12 December 2022 | 25 | 1,094,012 | 0.0023% | 703rd 461 |
| 30 June 2021 | 4,773 | 781,947 | 0.6104% | 242nd |